# Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

> **NCT01829958** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 201 (actual)

## Conditions studied

- Non Hodgkin Lymphoma (NHL)
- Diffuse Large B-cell Lymphoma (DLBCL)

## Interventions

- **DRUG:** rituximab
- **DRUG:** prednisone
- **BEHAVIORAL:** Geriatric Assessment

## Key facts

- **NCT ID:** NCT01829958
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-04
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01829958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01829958, "Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01829958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*